Literature DB >> 24448493

Re: Coffee consumption and risk of prostate cancer: an up-to-date meta-analysis.

A Discacciati1, N Orsini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24448493     DOI： 10.1038/ejcn.2013.292

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN： 0954-3007            Impact factor:   4.016


× No keyword cloud information.
  7 in total

1.  Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software.

Authors:  Nicola Orsini; Ruifeng Li; Alicja Wolk; Polyna Khudyakov; Donna Spiegelman
Journal:  Am J Epidemiol       Date:  2011-12-01       Impact factor: 4.897

2.  Methods for trend estimation from summarized dose-response data, with applications to meta-analysis.

Authors:  S Greenland; M P Longnecker
Journal:  Am J Epidemiol       Date:  1992-06-01       Impact factor: 4.897

3.  Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category.

Authors:  Jan Hamling; Peter Lee; Rolf Weitkunat; Mathias Ambühl
Journal:  Stat Med       Date:  2008-03-30       Impact factor: 2.373

4.  Coffee consumption and risk of localized, advanced and fatal prostate cancer: a population-based prospective study.

Authors:  A Discacciati; N Orsini; S-O Andersson; O Andrén; J-E Johansson; C S Mantzoros; A Wolk
Journal:  Ann Oncol       Date:  2013-03-18       Impact factor: 32.976

5.  Can meta-analysis be salvaged?

Authors:  S Greenland
Journal:  Am J Epidemiol       Date:  1994-11-01       Impact factor: 4.897

6.  Coffee consumption and risk of prostate cancer: an up-to-date meta-analysis.

Authors:  S Zhong; W Chen; X Yu; Z Chen; Q Hu; J Zhao
Journal:  Eur J Clin Nutr       Date:  2013-12-04       Impact factor: 4.016

7.  Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer--a dose-response meta-analysis.

Authors:  A Discacciati; N Orsini; A Wolk
Journal:  Ann Oncol       Date:  2013-11-24       Impact factor: 32.976
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.